A detailed history of Bruce & Co., Inc. transactions in Viatris Inc stock. As of the latest transaction made, Bruce & Co., Inc. holds 58,833 shares of VTRS stock, worth $764,829. This represents 0.31% of its overall portfolio holdings.

Number of Shares
58,833
Previous 58,252 1.0%
Holding current value
$764,829
Previous $695,000 10.07%
% of portfolio
0.31%
Previous 0.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$10.05 - $12.02 $5,839 - $6,983
581 Added 1.0%
58,833 $625,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $12,342 - $14,607
-1,287 Reduced 2.16%
58,252 $574,000
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $6,743 - $8,986
-733 Reduced 1.22%
59,539 $572,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $10,812 - $14,334
-1,240 Reduced 2.02%
60,272 $670,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $815,034 - $930,676
61,512 New
61,512 $833,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Bruce & Co., Inc. Portfolio

Follow Bruce & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.